Special Notice
NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research"
National Institutes of Health · Maryland
This is a notice (Special Notice), not a request for offers.
- Agency
- National Institutes of Health FederalNIH NCI
- Place
- Maryland
- Offers due
- November 20, 2026, 3:00 PM (ET) closes in 11 days
- Estimated value
- not stated
- Notice type
- Special Notice
- Category
- Consulting and research
- Posted
- October 20, 2026
Opens the notice on SAM.gov, with its attachments and how to respond.
Source: SAM.gov Contract Opportunities, the U.S. government's official list of federal contract opportunities.
Description
SOLCITATION H27-1001 Description of Work: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR). To obtain a copy of solicitation H27-1001 and other information concerning this opportunity, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/construction-idiq-contract or contact Matthew Hull (Contracts Manager) at [email removed] For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed's Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings. Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
Browse more bids
More open bids from this agency
- closes in 11 days
- closes in 11 days
- closes in 14 days
- closes in 11 days
- closes in 15 days
Similar open bids
- closes in 70 days
- closes in 70 days
- closes in 29 days
- closes in 11 days
- closes in 39 days
- closes in 1745 days
- closes in 4 days
- closes in 4 days
- closes in 11 days
- closes in 3 days